Bleichroeder LP

13F Holdings History for Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Symbol: CUE on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 6.13M shares
Security Ownership: 9.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Bleichroeder LP ownership in Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE)

2025-03-21 - Bleichroeder LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.13M shares of Cue Biopharma, Inc. Common Stock, $0.001 par value per share (CUE). This represents 9.99% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Bleichroeder LP	9.99%		$4.17M	6.13M			$0.68	13G/A	3/19/2025	21 Mar 2025 19:14:43
Bleichroeder LP	9.99%		$4.17M	6.13M			$0.68	13G/A	9/30/2024	7 Oct 2024 17:07:34

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	1.14%	+0.31%	$4.65M	6.82M	+1,821,924	+36.5%	$0.68	Q2 2025
3/31/2025	1.21%		$4.55M	5M			$0.91	Q1 2025
12/31/2024	1.37%		$5.45M	5M			$1.09	Q4 2024
9/30/2024	1.02%	+0.44%	$3.78M	5M	+2,135,634	+74.6%	$0.76	Q3 2024
6/30/2024	1.06%	+0.03%	$3.55M	2.86M	+106,578	+3.87%	$1.24	Q2 2024
3/31/2024	1.3%	+0.42%	$5.21M	2.76M	+1,000,000	+57%	$1.89	Q1 2024
12/31/2023	1.03%	+0.65%	$4.63M	1.76M	+1,000,000	+132%	$2.64	Q4 2023
9/30/2023	0.43%		$1.74M	755K			$2.30	Q3 2023
6/30/2023	0.56%		$2.76M	755K			$3.65	Q2 2023
3/31/2023	0.58%	-0.08%	$2.7M	755K	-106,250	-12.3%	$3.57	Q1 2023
12/31/2022	0.53%	+0.19%	$2.45M	861K	+306,278	+55.2%	$2.85	Q4 2022
9/30/2022	0.26%		$1.24M	555K			$2.23	Q3 2022
6/30/2022	0.29%	+0%	$1.38M	555K	+3,000	+0.54%	$2.49	Q2 2022
3/31/2022	0.48%	+0.31%	$2.69M	552K	+352,000	+176%	$4.88	Q1 2022
12/31/2021	0.35%	+0.04%	$2.26M	200K	+25,000	+14.3%	$11.31	Q4 2021
9/30/2021	0.41%		$2.55M	175K			$14.57	Q3 2021
6/30/2021	0.31%	+0.2%	$2.04M	175K	+100,000	+133%	$11.65	Q2 2021
3/31/2021	0.15%		$915K	75K			$12.20	Q1 2021
12/31/2020	0.18%	-0.18%	$938K	75K	-75,000	-50%	$12.51	Q4 2020
9/30/2020	0.4%	-0.04%	$2.26M	150K	-15,000	-9.09%	$15.05	Q3 2020
6/30/2020	0.72%		$4.04M	165K			$24.51	Q2 2020
3/31/2020	0.61%		$2.34M	165K			$14.19	Q1 2020
12/31/2019	0.41%		$2.62M	165K			$15.87	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.